Sequoia Backs Chinese Blood Glucose Monitoring Co

Beijing YiCheng Bioelectronics Technology Co. Ltd., a Chinese maker of blood glucose monitoring systems, has raised approximately $10.25 million in Series A funding from Sequoia Capital and PreIPO Capital. SSG Capital served as placement agent.

12 April 2010•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail